Skip to main content

Table 3 Echocardiographic findings at baseline and after 6 and 12 months

From: Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Parameter Baseline 6 months 12 months p value
LVEF (%) 41.1 ± 9.5 40.9 ± 11.0 39.5 ± 10.7 0.76
LVESV (ml) 93.4 ± 38.5 92.1 ± 36.6 96.3 ± 40.1 0.78
LVEDV (ml) 153.5 ± 45.0 152.1 ± 33.7 154.2 ± 36.9 0.96
WMSI 1.8 ± 0.5 1.8 ± 0.5 1.9 ± 0.5 0.43
  1. Data presented as mean ± standard deviation
  2. LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, LVEDV left ventricular end-diastolic volume, WMSI wall motion score index
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512